Amgen (NASDAQ:AMGN) PT Lowered to $275.00 at Jefferies Financial Group

Amgen (NASDAQ:AMGN – Free Report) had its price objective trimmed by Jefferies Financial Group from $325.00 to $275.00 in a research note issued to investors on Friday morning, FlyOnTheWall reports. Several other research firms have also commented on AMGN. Argus decreased their price target on shares of Amgen from $270.00 to $260.00 in a report […]

Related Keywords

Piper Sandler ,Jefferies Financial Group ,Tanglewood Legacy Advisors ,Amgen Inc ,Amgen Company Profile ,Strategic Investment Solutions Inc ,Glassy Mountain Advisors Inc ,Ruedi Wealth Management Inc ,Amgen ,Free Report ,Get Free Report ,Mountain Advisors ,Legacy Advisors ,Wealth Management ,Strategic Investment Solutions ,Amgen Daily ,Nasdaq Amgn ,Amgn ,Medical ,03116210 ,Lower Price Target ,Jefferies Financial Group Inc ,